Results 151 to 160 of about 3,761 (208)

Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy. [PDF]

open access: yesParasite
Al Samra L   +15 more
europepmc   +1 more source

Mycobacterium susceptibility to ivermectin by inhibition of eccD3, an ESX-3 secretion system component. [PDF]

open access: yesPLoS Comput Biol
Granados-Tristán AL   +10 more
europepmc   +1 more source

Menrath ulcer resulting in life-threatening anaemia in a cat. [PDF]

open access: yesJFMS Open Rep
Moberg FS, Kortegaard HE, Eriksen T.
europepmc   +1 more source

Efficacy and Safety of Ascending Dosages of Moxidectin and Moxidectin-albendazole Against Trichuris trichiura in Adolescents: A Randomized Controlled Trial

open access: yesClinical Infectious Diseases, 2020
Preventive chemotherapy is the main strategy to control soil-transmitted helminth (STH) infections. Albendazole and mebendazole are ubiquitously used, but they are not sufficiently effective against Trichuris trichiura.
Ladina Keller   +2 more
exaly   +2 more sources

In Vitro Efficacy of Moxidectin versus Ivermectin against Sarcoptes scabiei [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2017
Moxidectin is under consideration for development as a treatment for human scabies. As some arthropods show decreased sensitivity to moxidectin relative to ivermectin, it was important to assess this for Sarcoptes scabiei. In vitro assays showed that the
Kate Mounsey   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy